Relevant bibliographies by topics / Cystic fibrosis, bronchopulmonary disease, nursing diagnosis

Contents

  1. Journal articles
  2. Book chapters

Academic literature on the topic 'Cystic fibrosis, bronchopulmonary disease, nursing diagnosis'

Author: Grafiati
Published: 24 April 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cystic fibrosis, bronchopulmonary disease, nursing diagnosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cystic fibrosis, bronchopulmonary disease, nursing diagnosis"

1

Farrell, Philip M., Zhanhai Li, Michael R. Kosorok, Anita Laxova, Christopher G. Green, Jannette Collins, Hui-Chuan Lai, Michael J. Rock, and Mark L. Splaingard. "Bronchopulmonary Disease in Children with Cystic Fibrosis after Early or Delayed Diagnosis." American Journal of Respiratory and Critical Care Medicine 168, no. 9 (November 2003): 1100–1108. http://dx.doi.org/10.1164/rccm.200303-434oc.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

De los Rios Perez, A. M., O. Asensio de la Cruz, M. Espasa Soley, M. Bosque Garcia, D. Fontanals Aymerich, and N. Lopez Galvany. "Influence of early diagnosis in the development of bronchopulmonary disease in cystic fibrosis." Journal of Cystic Fibrosis 9 (June 2010): S60. http://dx.doi.org/10.1016/s1569-1993(10)60235-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Eickmeier, Olaf, Nikolaus Rieber, Jonas Eckrich, Andreas Hector, Ute Graeppler-Mainka, and Dominik Hartl. "Immune Response, Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Lung Disease." Current Pharmaceutical Design 19, no. 20 (April 1, 2013): 3669–78. http://dx.doi.org/10.2174/13816128113199990349.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zander, Dani S. "Allergic Bronchopulmonary Aspergillosis: An Overview." Archives of Pathology & Laboratory Medicine 129, no. 7 (July 1, 2005): 924–28. http://dx.doi.org/10.5858/2005-129-924-abaao.

Full text
Abstract:
Abstract This article provides an overview of the major pathologic manifestations of allergic bronchopulmonary aspergillosis; patient characteristics; clinical, radiographic, and laboratory features of the disease; and current knowledge about its pathogenesis. Although allergic bronchopulmonary aspergillosis is an infrequent complication of asthma or cystic fibrosis, recognition of this disorder is important to avoid progression of bronchiectasis and lung parenchymal damage. Clinical, laboratory, and radiographic criteria allow for diagnosis of most cases, but the pathologist may encounter clinically unsuspected or atypical cases that require morphologic confirmation.
APA, Harvard, Vancouver, ISO, and other styles
5

Rekalova, O. M. "ASTHMA AS A MASK OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS: DIAGNOSIS AND TREATMENT." Ukrainian Pulmonology Journal 29, no. 4 (2021): 57–63. http://dx.doi.org/10.31215/2306-4927-2021-29-4-57-63.

Full text
Abstract:
ASTHMA AS A MASK OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS: DIAGNOSIS AND TREATMENT O. M. Rekalova Abstract Asthma is a heterogeneous diseases with multiple phenotypes, 5–10 % of which are associated with severe course of disease, resistant to standard therapy. Allergic bronchopulmonary aspergillosis (ABPA), being a separate disease (ICD-10: B44.9 — aspergillosis unspecified), may mimic asthma. A literature review of major statements regarding ABPA, focusing on definition, pathogenesis, diagnostic criteria, association of different forms of asthma with fungal sensitization and Th2-response, stage, radiological picture, diagnostic algorithm in asthma and cystic fibrosis, characteristics of major applicable lab tests, principles and algorithm of treatment of ABPA patients, and treatment prospects. Lung radiological data using computer modeling from patient with ABPA (clinical case) has been presented as an illustration. Key words: allergic bronchopulmonary aspergillosis (ABPA), asthma, diagnosis, treatment. Ukr. P
APA, Harvard, Vancouver, ISO, and other styles
6

Maguire, Sabine, Patricia Moriarty, Edward Tempany, and Muiris FitzGerald. "Unusual Clustering of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis." Pediatrics 82, no. 6 (December 1, 1988): 835–39. http://dx.doi.org/10.1542/peds.82.6.835.

Full text
Abstract:
Allergic bronchopulmonary aspergillosis has been recognized in association with cystic fibrosis in children since 1965. Since then, however, there have been a paucity of reports of pediatric cystic fibrosis complicated by allergic bronchopulmonary aspergillosis, and, in most cases, these have been diagnosed retrospectively. A cluster of five acute cases seen during a 4-month period in a single cystic fibrosis center with a systemic illness and deterioration in respiratory status are described. In all five patients, reversible bronchoconstriction and infiltrative changes on x-ray films suggested the diagnosis. This was confirmed by the presence of (1) peripheral blood eosinophilia, (2) elevated total IgE and Aspergillus fumigatus-specific IgE, and (3) circulating serum precipitins against A fumigatus in all cases. All children tested had positive type 1 immediate hypersensitivity to skin tests for A fumigatus, in sputum eosinophilia, and Aspergillus cultured from sputum. Only three of five children were previously noted to be atopic and none had severe advanced suppurative lung disease. All children had previously received bronchodilator therapy and appropriate antibiotics. Following treatment with corticosteroids, acute symptoms and radiologic changes resolved for 1 to 5 months. To date, no children have had recurrence of their allergic bronchopulmonary aspergillosis while receiving alternate-day steroid treatment for 6 months.
APA, Harvard, Vancouver, ISO, and other styles
7

Kozlov, A. V., O. A. Gusyakova, A. A. Ereshchenko, and A. V. Khaliulin. "DIAGNOSTIC POSSIBILITIES OF MODERN BIOCHEMICAL STUDY OF SPUTUM FROM PATIENTS WITH CYSTIC FIBROSIS (LITERATURE REVIEW)." Russian Clinical Laboratory Diagnostics 64, no. 1 (April 29, 2019): 24–28. http://dx.doi.org/10.18821/0869-2084-2019-64-1-24-28.

Full text
Abstract:
The review presents the pathobiochemical and molecular mechanisms of sputum formation in patients with cystic fibrosis associated with the pathophysiological features of the disease. Statistical data on the prevalence of this pathology in the world and in the Russian Federation are presented. The mechanisms of sputum formation and disorders of the mucociliary apparatus, leading to the accumulation of viscous bronchopulmonary secret in cystic fibrosis, are considered. The principles of the relationship between the rheological properties of sputum and the formation of inflammation in the lungs with the addition of a concomitant specific microflora in the bronchopulmonary system in patients with cystic fibrosis are presented. Describes the opportunities for biochemical studies of sputum of patients with this pathology: determining the activity of enzymes (myeloperoxidase), the content of proteinase inhibitors (α2-macroglobulin and α1-antitrypsin) and proinflammatory cytokines (IL-8 and TNFa), concentrations of iron and ferriferous proteins (lactoferrin and ferritin), which makes biochemical studies of sputum available, non-invasive, quick and cost-effective method of diagnosis, which can be widely used as an auxiliary laboratory method and makes it possible to use these metabolites as diagnostic markers to assess the severity of inflammation and infection of the lower respiratory tract and predict the development of respiratory complications in patients with cystic fibrosis.
APA, Harvard, Vancouver, ISO, and other styles
8

Strawhacker, MaryAnn Tapper, and Joyce Wellendorf. "Caring for Children With Cystic Fibrosis: A Collaborative Clinical and School Approach." Journal of School Nursing 20, no. 1 (February 2004): 5–15. http://dx.doi.org/10.1177/10598405040200010301.

Full text
Abstract:
Earlier diagnosis and more effective treatments have improved both morbidity and mortality associated with cystic fibrosis, making regular school attendance a reality. School nurses have a unique opportunity to assist students with cystic fibrosis successfully manage their disease. Medical treatment for cystic fibrosis can be complex, leaving students and families in need of health consultation and support. The clinic and school nurse each brings a unique perspective to cystic fibrosis care management. Working to understanding perspectives across settings and looking for ways to collaborate through mutual planning and goal setting is an ideal way to support families and promote achievement of optimal health status for students.
APA, Harvard, Vancouver, ISO, and other styles
9

Baumann, Taylor, Shailendra Das, Jill Ann Jarrell, Yuriko Nakashima-Paniagua, Edith Adriana Benitez, Maria Carolina Gazzaneo, and Natalie Villafranco. "Palliative Care in Pediatric Pulmonology." Children 8, no. 9 (September 13, 2021): 802. http://dx.doi.org/10.3390/children8090802.

Full text
Abstract:
Children with End Stage Lung Disease (ESLD) are part of the growing population of individuals with life-limiting conditions of childhood. These patients present with a diverse set of pulmonary, cardiovascular, neuromuscular, and developmental conditions. This paper first examines five cases of children with cystic fibrosis, bronchopulmonary dysplasia, neuromuscular disease, pulmonary hypertension, and lung transplantation from Texas Children’s Hospital. We discuss the expected clinical course of each condition, then review the integration of primary and specialized palliative care into the management of each diagnosis. This paper then reviews the management of two children with end staged lung disease at Hospital Civil de Guadalajara, providing an additional perspective for approaching palliative care in low-income countries.
APA, Harvard, Vancouver, ISO, and other styles
10

Lattanzi, Claudia, Giulia Messina, Valentina Fainardi, Maria Candida Tripodi, Giovanna Pisi, and Susanna Esposito. "Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: An Update on the Newest Diagnostic Tools and Therapeutic Approaches." Pathogens 9, no. 9 (August 31, 2020): 716. http://dx.doi.org/10.3390/pathogens9090716.

Full text
Abstract:
Cystic fibrosis (CF), the most common autosomal-recessive genetic disease in the Caucasian population, is characterized by frequent respiratory infections and progressive lung disease. Fungal species are commonly found in patients with CF, and among them, Aspergillus fumigatus is the most frequently isolated. While bacteria, particularly Pseudomonas aeruginosa, have a well-established negative effect on CF lung disease, the impact of fungal infections remains unclear. In patients with CF, inhalation of Aspergillus conidia can cause allergic bronchopulmonary aspergillosis (ABPA), a Th2-mediated lung disease that can contribute to disease progression. Clinical features, diagnostic criteria and treatment of ABPA are still a matter of debate. Given the consequences of a late ABPA diagnosis or the risk of ABPA overdiagnosis, it is imperative that the diagnostic criteria guidelines are reviewed and standardized. Along with traditional criteria, radiological features are emerging as tools for further classification as well as novel immunological tests. Corticosteroids, itraconazole and voriconazole continue to be the bedrock of ABPA therapy, but other molecules, such as posaconazole, vitamin D, recombinant INF-γ and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators, have been showing positive results. However, few studies have been conducted recruiting CF patients, and more research is needed to improve the prevention and the classification of clinical manifestations as well as to personalize treatment. Early recognition and early treatment of fungal infections may be fundamental to prevent progression of CF disease. The aim of this narrative review is to give an update on ABPA in children with CF.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Cystic fibrosis, bronchopulmonary disease, nursing diagnosis"

1

Robinson, Terry, and Jane Scullion. "Cystic fibrosis." In Oxford Handbook of Respiratory Nursing, 285–98. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198831815.003.0010.

Full text
Abstract:
Cystic fibrosis (CF) is the most common, life-threatening, and recessively inherited disease in the Western world. This chapter provides an overview of the condition, including its aetiology, pathology, and genetics. It then covers the clinical presentations and confirmation of diagnosis of CF, complications (respiratory, gastrointestinal, pancreatic, bowel, hepatic, reproductive, and diabetic). Anyone recognized as having high risk of having a baby with CF and in whom pregnancy is contemplated, or who has a newborn with CF, should be offered screening and early genetic advice. Care and management are described in detail, including nutrition, physiotherapy, infection control, antibiotics, the transition from paediatric to adult care, transplant, and end-of-life care.
APA, Harvard, Vancouver, ISO, and other styles
2

Greenberger, Paul A. "Allergic Bronchopulmonary Aspergillosis." In Asthma, 21–31. Oxford University Press, 2014. http://dx.doi.org/10.1093/med/9780199918065.003.0003.

Full text
Abstract:
Allergic bronchopulmonary aspergillosis (ABPA), a disease that complicates asthma and cystic fibrosis, is in the differential diagnosis of pulmonary infiltrates, peripheral blood or sputum eosinophilia, elevated total serum immunoglobulin E concentration, and bronchiectasis, any or all of which may occur in patients with established asthma. ABPA is one of the most important comorbid, coexisting subtypes of asthma because it results in irreversible lung destruction and may convert intermittent or persistent mild asthma into persistent severe asthma. The fact that the treatment of choice to clear pulmonary infiltrates and sputum eosinophilia is an oral steroid but not antifungal therapy remains true after 50 years of attempts to improve our understanding and treatment of ABPA. It remains to be established whether monoclonal antibodies will contribute to meaningful improvement in management of patients, or what combination therapy will be optimum instead of relying on oral glucocorticoids. Certainly, innovative, safe, and effective approaches to treatment are needed to decrease the harmful impact that untreated or inadequately treated ABPA can have on patients with asthma.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cystic fibrosis, bronchopulmonary disease, nursing diagnosis' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography